Mitterhofer A P, Pietropaolo V, Barile M, Tinti F, Fioriti D, Mischitelli M, Limonta A, Meçule A, Ferretti G, Poli L, Chiarini F, Berloco P B, Taliani G
Department of Nephro-Urology, 1st Faculty of Medicine and Surgery, Sapienza University of Rome, Rome, Italy.
Transplant Proc. 2010 May;42(4):1142-5. doi: 10.1016/j.transproceed.2010.03.130.
Polyomavirus BK (BKV) infection is ubiquitous in the human population. Under immunosuppression, BKV can undergo reactivation resulting in viral replication. What really happens in the early hours posttransplantation is not clearly defined; the meaning of early viremia and viruria is not clear. BKV viremia is considered a marker of infection. The aim of our study was to investigate the prevalence of early BKV infection in kidney transplant patients, to evaluate the relationship to infections at 3 and 6 months and the association with recipient, donor, and graft features. We enrolled 36 kidney transplanted patients from May 2006 to April 2007. BKV load was measured on plasma and urine samples by Q-PCR at 12 hours (T(0)/early) as well as 3 (T(3)) and 6 (T(6)) months thereafter. A high percentage of BKV infections were detectable in the first hours after transplantation (33.3%), which remained unchanged to month 6 post transplantation. Moreover, patients who were positive at T(0) had a high probability of remaining positive thereafter. The number of copies in plasma samples tended to increase at 3 months and to decrease thereafter, whereas the urine viral load tended to steadily increase. Among BKV-positive patients, we identified 2 groups according to viremic state at T(0): 9 patients (group A); who were already positive and remained so to T(6) 5 and 3 patients who turned positive at 3 or at 6 months, respectively (group B). Group A included 75% of positive patients at T(0) and 90% of positive patients at either T(3) or T(6) (P = .007). The most important contribution of our study was to highlight the presence of BKV infection in renal transplant recipients from the first hours posttransplantation. This condition seemed to be the most important risk factor for persistent infection in the first 6 months.
多瘤病毒BK(BKV)感染在人群中普遍存在。在免疫抑制状态下,BKV可重新激活,导致病毒复制。移植后早期实际发生了什么尚不清楚;早期病毒血症和病毒尿的意义尚不明确。BKV病毒血症被认为是感染的一个标志。我们研究的目的是调查肾移植患者早期BKV感染的患病率,评估其与3个月和6个月时感染的关系以及与受者、供者和移植物特征的关联。我们纳入了2006年5月至2007年4月期间的36例肾移植患者。通过定量聚合酶链反应(Q-PCR)在移植后12小时(T(0)/早期)以及此后的3个月(T(3))和6个月(T(6))对血浆和尿液样本进行BKV载量检测。移植后最初几小时内可检测到高比例的BKV感染(33.3%),至移植后6个月保持不变。此外,在T(0)时呈阳性的患者此后持续呈阳性的可能性很高。血浆样本中的拷贝数在3个月时趋于增加,此后减少,而尿液病毒载量趋于稳步增加。在BKV阳性患者中,根据T(0)时的病毒血症状态我们确定了两组:9例患者(A组),在T(0)时已呈阳性并持续至T(6);5例和3例患者分别在3个月或6个月时转为阳性(B组)。A组包括T(0)时75%的阳性患者以及T(3)或T(6)时90%的阳性患者(P = 0.007)。我们研究最重要的贡献是突出了肾移植受者在移植后最初几小时内就存在BKV感染。这种情况似乎是前6个月持续性感染最重要的危险因素。